CA2464660A1 - Solution d'inhalation a base d'albuterol, et systeme, kit et methode permettant de soulager les symptomes de l'asthme pediatrique - Google Patents

Solution d'inhalation a base d'albuterol, et systeme, kit et methode permettant de soulager les symptomes de l'asthme pediatrique Download PDF

Info

Publication number
CA2464660A1
CA2464660A1 CA002464660A CA2464660A CA2464660A1 CA 2464660 A1 CA2464660 A1 CA 2464660A1 CA 002464660 A CA002464660 A CA 002464660A CA 2464660 A CA2464660 A CA 2464660A CA 2464660 A1 CA2464660 A1 CA 2464660A1
Authority
CA
Canada
Prior art keywords
inhalation solution
albuterol
containers
pediatric
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002464660A
Other languages
English (en)
Other versions
CA2464660C (fr
Inventor
Imtiaz Chaudry
Partha Banerjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Specialty LP
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/034,829 external-priority patent/US6702997B2/en
Application filed by Individual filed Critical Individual
Publication of CA2464660A1 publication Critical patent/CA2464660A1/fr
Application granted granted Critical
Publication of CA2464660C publication Critical patent/CA2464660C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Solution d'inhalation à base d'albutérol, et système, kit et méthode permettant de soulager le bronchospasme chez les enfants souffrant d'asthme. Dans un mode de réalisation, la solution selon la présente invention est une dose unitaire stérile, prémélangée et prémesurée d'albutérol pour des patients asthmatiques ayant de 2 à 12 ans. Cette solution peut être exempte de produits chimiques anti-microbiens tels que le chlorure de benzalconium. Dans un autre mode de réalisation, la solution selon la présente invention contient environ 0,63 mg ou environ 1,25 mg d'albutérol.
CA2464660A 2001-10-26 2002-10-18 Solution d'inhalation a base d'albuterol, et systeme, kit et methode permettant de soulager les symptomes de l'asthme pediatrique Expired - Fee Related CA2464660C (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US34820301P 2001-10-26 2001-10-26
US60/348,203 2001-10-26
US10/034,829 US6702997B2 (en) 2001-10-26 2001-12-27 Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US10/034,829 2001-12-28
AU32975/02 2002-04-05
AU32975/02A AU3297502A (en) 2001-10-26 2002-04-05 An albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
JP2002-145456 2002-04-11
JP2002145456A JP2003212764A (ja) 2001-10-26 2002-04-11 小児喘息の症状を緩和するためのアルブテロール吸入溶液、システム、キット及び方法
PCT/US2002/033352 WO2003037317A1 (fr) 2001-10-26 2002-10-18 Solution d'inhalation a base d'albuterol, et systeme, kit et methode permettant de soulager les symptomes de l'asthme pediatrique

Publications (2)

Publication Number Publication Date
CA2464660A1 true CA2464660A1 (fr) 2003-05-08
CA2464660C CA2464660C (fr) 2011-12-20

Family

ID=27422969

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2464660A Expired - Fee Related CA2464660C (fr) 2001-10-26 2002-10-18 Solution d'inhalation a base d'albuterol, et systeme, kit et methode permettant de soulager les symptomes de l'asthme pediatrique

Country Status (6)

Country Link
EP (1) EP1441709A1 (fr)
JP (1) JP2006513129A (fr)
CA (1) CA2464660C (fr)
MX (1) MXPA04003928A (fr)
NZ (1) NZ550304A (fr)
WO (1) WO2003037317A1 (fr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
GB8825892D0 (en) * 1988-11-04 1988-12-07 Fisons Plc Pharmaceutical composition
WO1994013262A1 (fr) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Formulations de solutions medicinales aerosol stabilisees
AU685225B2 (en) * 1994-02-10 1998-01-15 Yamanouchi Pharmaceutical Co., Ltd. Novel carbamate derivative and medicinal composition containing the same
EP0840733B1 (fr) * 1995-07-11 2001-10-24 Merck & Co., Inc. Sel de bisulfate de triazolymethyle-indole ethylamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
JP3676674B2 (ja) * 1997-10-09 2005-07-27 シェーリング コーポレイション 噴霧のためのモメタゾンフロエート懸濁液
JP2003525099A (ja) * 2000-03-01 2003-08-26 グラクソ グループ リミテッド 定量噴霧式吸入器
US6451289B2 (en) * 2000-03-24 2002-09-17 Sepracor Inc. Albuterol formulations

Also Published As

Publication number Publication date
EP1441709A1 (fr) 2004-08-04
WO2003037317A1 (fr) 2003-05-08
JP2006513129A (ja) 2006-04-20
NZ550304A (en) 2008-05-30
CA2464660C (fr) 2011-12-20
MXPA04003928A (es) 2005-03-31

Similar Documents

Publication Publication Date Title
EP0381522B1 (fr) Sprays pour le traitement des infections des voies respiratoires
CA2464735A1 (fr) Solution d'inhalation a base d'albuterol et d'ipratropium, et systeme, kit et methode permettant de soulager les symptomes de la bronchopneumopathie chronique obstructive
US6702997B2 (en) Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
TW300886B (fr)
ES2792682T3 (es) Métodos para el tratamiento de enfermedades pulmonares con estabilizadores de mastocitos
AU2002347948A1 (en) Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US6632842B2 (en) Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030191151A1 (en) Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
EP0409662B1 (fr) Préparation atomisées à base de zinc
AU2004281532B2 (en) Liquid preparation containing tobramycin
JPH02196716A (ja) 薬学的溶液
WO2004091536A2 (fr) Solution d'inhalation d'albuterol et d'ipratropium inhalation, kit et procede de soulagement de symptomes de maladie pulmonaire obstructive chronique
CA2464660A1 (fr) Solution d'inhalation a base d'albuterol, et systeme, kit et methode permettant de soulager les symptomes de l'asthme pediatrique
US20030140920A1 (en) Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
EP4125814A1 (fr) Composés iodé pour le traitement de pathogènes respiratoires
US20050175544A1 (en) Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
AU2006202585B2 (en) An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
AU2002353825B2 (en) An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
CA3169607C (fr) Composes iode pour le traitement de pathogenes respiratoires
US8084461B2 (en) Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
CA1282705C (fr) Compose pour traiter les symptomes du rhume ou pour la prevention de cettemaladie
AU2002353825A1 (en) An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
AU2006202584A1 (en) An albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
Engel PROBLEMS ASSOCIATED WITH THE USE OF DRUGS ADMINISTERED BY INTERMITTENT POSITIVE PRESSURE VENTILATION∗

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20201019